Stocks
Axsome Therapeutics, Inc.AXSM
NASDAQHealthcareBiotechnology$156.08+1.27%
A biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders, including depression, migraine, and sleep-related conditions. Its portfolio includes approved treatments such as Auvelity for major depressive disorder and Sunosi for excessive...
Market Cap: $8.0B52W Range: $86.99 – $191.50
Congressional Interest in Axsome Therapeutics, Inc. (AXSM)
1 member of Congress has disclosed 1 trade in Axsome Therapeutics, Inc. (AXSM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AXSM?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |